Reginald J. Sanders, M.D. Named as New President of the ASRS

Dr. Reginald J. Sanders, a distinguished physician affiliated with the Retina Group of Washington (RGW) and PRISM Vision Group, has been named as the new president of the American Society of Retina Specialists (ASRS).

Dr. Sanders holds the distinction of being the first African American to assume the presidency of ASRS. Additionally, his affiliation with PRISM Vision Group marks another milestone, making him the first physician from PRISM to serve in this esteemed position.

Throughout his career, Dr. Sanders has been a driving force in advancing the field of ophthalmology. His contributions are evident through a myriad of academic publications, impactful presentations, and a well-deserved collection of honors and awards. Notably, he was elected as a charter inductee into the Retina Hall of Fame.

In 2021, Dr. Sanders received the Packo Service Award, a testament to his exceptional dedication and service to the ASRS. This accolade further underscores his commitment to the society and its mission to advance the understanding and treatment of retinal diseases.

Dr. Sanders began his journey in the realm of vitreoretinal diseases and surgery after completing a fellowship at the Retina Associates/Massachusetts Eye and Ear Infirmary/Harvard Medical School in Boston. His residency in ophthalmology took place at Wills Eye Hospital in Philadelphia, where he was named co-chief resident. The foundation of his medical education was laid during his internship at Yale-New Haven Hospital, where he also earned his medical degree.

With a prolific academic background, Dr. Sanders boasts a publication record of more than 50 papers, articles, and presentations. His expertise extends beyond national borders, as he has lectured both nationally and internationally. Dr. Sanders has also played a crucial role as an investigator/sub-investigator in numerous studies focusing on new retinal treatments. Notably, he served as the principal investigator for the Lucentis treatment for wet age-related macular degeneration.